Callahan Advisors, LLC
Source: SEC Form 13F · as of Mar 2026Callahan Advisors, LLC holds 14 biotech & pharma companies tracked by BioSniper, totaling $106.0M in value as of Mar 2026 (SEC Form 13F).
Companies held
14
Total value held
$106.0M
| Company | Shares | Value |
|---|---|---|
| JNJJOHNSON & JOHNSON | 109,484 | $26.8M |
| LLYELI LILLY & Co | 20,163 | $18.5M |
| PFEPFIZER INC | 562,533 | $15.8M |
| UNHUnitedHealth Group Incorporated Common Stock (DE) | 38,432 | $10.4M |
| ABTABBOTT LABORATORIES | 74,902 | $7.7M |
| IQVIQVIA Holdings Inc. | 44,491 | $7.6M |
| CAHCardinal Health Inc. | 27,117 | $5.7M |
| DVADaVita Inc. | 35,139 | $5.4M |
| MRKMerck & Co., Inc. | 23,402 | $2.8M |
| PMPhilip Morris International Inc | 12,948 | $2.1M |
| ABBVAbbVie Inc. | 5,309 | $1.2M |
| BMYBRISTOL MYERS SQUIBB CO | 13,291 | $806K |
| REGNREGENERON PHARMACEUTICALS, INC. | 924 | $714K |
| GILDGILEAD SCIENCES, INC. | 3,156 | $440K |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.